Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, tiredness is a recognised side effect of Wegovy (semaglutide). Clinical trials and post-market reports confirm that fatigue affects a meaningful proportion of people starting treatment, particularly in the early weeks. It is rarely severe, usually short-lived, and almost always manageable. That said, understanding why it happens and when to take it seriously makes a real difference to how you get through the adjustment period. The NHS medicines page for semaglutide lists fatigue among the known side effects, and it tends to cluster with the gastrointestinal symptoms that most people notice after starting or increasing their dose. Wegovy is a prescription-only medicine; a prescriber assesses whether it is clinically suitable for you before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy works by activating GLP-1 receptors in the brain and gut, slowing gastric emptying and significantly reducing appetite. The knock-on effect of eating less (sometimes far less than usual) is that your body receives fewer calories than it is used to. For most people that calorie drop is precisely the point, but the adjustment is not always smooth. Your blood sugar may run a little lower than your baseline, energy availability dips, and the brain notices. Add to that the nausea that many people experience in the first weeks, and it is easy to see why tiredness follows.
This is not a sign the medicine is harming you. It is a sign your physiology is responding to it. The STEP 1 trial, published in the New England Journal of Medicine, documented fatigue alongside the gastrointestinal side effects that were most common in the early treatment period. The pattern is consistent: symptoms peak in the first four to eight weeks, then ease as appetite and intake find a new equilibrium.
A small practical shift helps at this stage. Eating enough protein at each meal (even when appetite is low) gives your body a steadier energy source. Staying well hydrated matters too; dehydration from nausea or reduced fluid intake amplifies fatigue considerably. If you feel most drained mid-morning, it is worth asking whether breakfast contained enough protein to carry you through. These are small adjustments, but they add up.
Semaglutide starts at 0.25 mg and is titrated upward by your prescriber, typically in roughly four-weekly steps toward the 2.4 mg maintenance dose. Each increase can briefly restart the fatigue cycle. People who sailed through the early weeks sometimes find themselves caught out by tiredness again after a new pen arrives. This is normal and follows the same biological logic: a higher dose suppresses appetite more strongly, intake drops again, and the body adjusts again.
The key difference at this stage is that you already know the pattern. That matters psychologically. Many people describe the second or third dose-increase fatigue as less alarming precisely because they recognise it. If you are struggling with how tiredness and other symptoms are stacking up, the full Wegovy side effects overview puts each symptom in context and helps you distinguish what is expected from what needs attention.
One thing worth noting: if you are also taking other medicines that can cause drowsiness, a dose increase may temporarily intensify the combined effect. Raise this with your prescriber; they can advise whether timing or sequencing of medicines is worth reviewing. For questions about any specific interaction, the nume support team is available seven days a week, sorry, the nume support team.
Persistent, worsening exhaustion that does not ease after a few weeks is worth investigating properly. A handful of causes are worth being aware of. First, significant calorie restriction on top of Wegovy's appetite suppression can push intake so low that fatigue becomes chronic rather than transitional, undereating is genuinely counterproductive on this treatment. Second, semaglutide slows gastric emptying, which can affect the absorption of some oral medicines, including thyroid medications; if you take levothyroxine and notice fatigue worsening, flag it with your GP.
Third, and less commonly, severe gastrointestinal symptoms can cause dehydration significant enough to affect energy and kidney function. The MHRA Yellow Card scheme exists so that patients can report side effects that feel unusual or serious, it is straightforward to use and genuinely contributes to ongoing safety monitoring of medicines like Wegovy.
If you experience any of the following, seek medical attention rather than waiting: severe stomach pain that radiates to the back, confusion or inability to keep fluids down for more than 24 hours, or heart palpitations alongside fatigue. These go beyond routine adjustment and need clinical assessment. For context on what extreme fatigue on semaglutide looks like and when it crosses a line, the page on extreme tiredness on Wegovy covers the distinction in detail.
Fatigue rarely arrives alone. The people who find tiredness most disruptive are often also managing nausea, reduced appetite, and occasionally headaches, all from the same underlying mechanism. Semaglutide affects multiple systems at once, and the side effects tend to cluster. If you are curious whether the fatigue picture looks different in the broader context of how semaglutide affects the body, the semaglutide and tiredness overview covers both Wegovy and the wider semaglutide family.
A separate question that comes up in the same conversations: hair thinning. Some people on Wegovy notice hair loss a few months into treatment, not a direct drug effect, but typically telogen effluvium triggered by rapid weight loss and the calorie change. If that is also on your mind, the page on whether Wegovy causes hair loss explains the mechanism clearly.
Wegovy is a prescription-only treatment, and the dose schedule, your individual response, and any symptoms you notice are all things your prescriber should be in the loop on. If you are still deciding whether Wegovy is right for you, the Wegovy treatment overview covers eligibility, how it works, and what to expect. For cost context, the Wegovy pricing page sets out how private treatment is structured and what is included. When you are ready to speak to a prescriber, you can start your free consultation and have your answers reviewed the same day by a real clinician.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.